Design and Evaluation of Gastro-Retentive Drug Delivery System for Glimepiride using Design of Experiment
Abstract
Glimepiride, oral sulfonyl urea, BCS class-II drug is used to treat diabetes (type-II). Due to its low solubility, it is an ideal candidate for solubility enhancement, leading to better bioavailability and subsequent dose. In the present study, the solid dispersion technique was used to improve the solubility using solvent evaporation method. The solid dispersions were prepared using affnisol 912 as a solubility enhancer. The prepared solid dispersions were evaluated for solubility in 0.1N HCl pH 1.2 and phosphate buffer pH 7.8 medium. The solubility of glimepiride in optimized solid dispersion (SD1) formulation was 682.44 μg/mL compared to 6.88 μg/mL for pure drug in pH 7.8 medium. The solid dispersion (SD1) was further formulated into the tablets. The gastro-retentive and mucoadhesive properties were contributed to the tablets by HPMC K4M and Carbopol 940, respectively. Factorial design (Central composite design) was used to optimize the gastro-retentive tablets. The tablet formulations showed good mucoadhesive properties and drug release up to 12 hours in pH 1.2 with 0.5% SLS medium. The optimized formulation (F2) showed cumulative drug release up to 97.20 ± 0.99% in 12 hours. The drug release kinetics also showed that the drug is release by dissolution and diffusion from the drug matrix. The gastro-retention studies in rabbits also showed the tablets remain within the GIT up to 12 hours as confirmed by x-ray images.
Keywords:
Glimepiride, Solid dispersion, Affnisol, Solubility enhancement, gastro-retentive tablets, x-ray imaging.DOI
https://doi.org/10.25004/IJPSDR.2022.140114References
Kagan L, Lapidot N, Afargan M, Kirmayer D, Moor E, Mardor Y, et al.: Gastroretentive accordion pill: Enhancement of riboflavin bioavailability in humans. J. Controlled Release 2006;113:208– 215.
Murphy C, Pillay V, Choonara Y, du Toit L: Gastroretentive drug delivery systems: Current developments in novel system design and evaluation. Curr. Drug Delivery 2009;6:451–460.
Chawla G, Gupta, P, Koradia, V., Bansal, A.K., 2003. Gastroretention: A means to address regional variability in intestinal drug absorption. Pharm. Technol. 2002; 27: 50–68.
Streubel A, Siepmann J, Bodmeier R: Gastroretentive Drug Delivery Systems. Expert Opin. Drug Delivery 2006;3:217–233.
Gökbulut E, Vural İ, Aşıkoğlu M, Özdemir N. Floating drug delivery system of itraconazole: Formulation, in-vitro and in-vivo studies. J. Drug Delivery Sci. Technol. 2019;49:491–501.
Timmermans J, Moës AJ: How well do floating dosage forms float? Int. J. Pharm. 1990;62:207–216.
Lobenberg R, Amidon GL: Modern bioavailability, bioequivalence and biopharmaceutics classification system. New Scientific Approaches to International Regulatory Standards. Eur. J. Pharm. Biopharm. 2000;50:3–12.
Chaudhari MD, Sonawane RO, Zawar L, Nayak S, Bari SK: Solubility and dissolution enhancement of poorly water soluble Glimepiride by using solid dispersion technique. Int. J. Pharm. Pharm. Sci. 2012;4:534–539.
Kiran T, Shastri N, Sistla R, Sadanandam M: surface solid dispersion of glimepiride for enhancement of dissolution rate. Int. J. PharmTech Res. 2009;1:822–831.
Ning X, Sun J, Han X, Wu Y, Yan Z, Han J, et al.: Strategies to improve dissolution and oral absorption of Glimepiride tablets: Solid dispersion versus micronization techniques. Drug Dev. Ind. Pharm. 2011;37:727–736.
Arias MJ, Ginés JM, Moyano JR, Pérez-Martinez JI, Rabasco AM: Influence of the preparation method of solid dispersions on their dissolution rate: Study of triamterene-D-mannitol system. Int. J. Pharm. 1995;123:25–31.
Leuner C: Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000;50:47–60.
Verheyen S, Blaton N, Kinget R, Van den Mooter G: Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int . J. Pharm. 2002;249:45–58.
British pharmacopoeia. London, The Stationery Office, 2019.
Sharma A, Jain CP. Preparation and characterization of solid dispersions of carvedilol with PVP K30. Res Pharm Sci. 2010;5:49-56.
Muralichand G, Bhikshapathi DV: Preparation and in vitro evaluation of solid dispersions containing Nifedipine. Int. J. Pharm. Sci. Drug Res. 2018;10:260-7.
Viana AL, Doriguetto AC, Viana OM, Ruela AL, Freitas JT, Souto BE, Araujo MB, Paula FA. Pharmacokinetics and pharmacodynamics of Glimepiride polymorphs. Int. J. Pharm. 2018;553:272–80.
Dudhipala N, Narala A, Janga KY, Bomma R: Amoxycillin Trihydrate Floating-Bioadhesive Drug Delivery System for Eradication of Helicobacter pylori: Preparation, In Vitro and Ex Vivo Evaluation. J. Bioequivalence Bioavailability 2016;8:118–124.
Bayuo J, Abukari MA, Pelig-Ba KB. Optimization using central composite design (CCD) of response surface methodology (RSM) for biosorption of hexavalent chromium from Aqueous Media. Appl. Water Sci. 2020;10.
Gil EC, Colarte AI, Bataille B, Pedraz JL, Rodríguez F, Heinämäki J: Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. Int. J. Pharm. 2006;317:32–39.
Gowthami B, Krishna SVG, Rao DS. Formulation of tablets in capsule system: Statistical optimization for chronotherapeutic drug delivery of propranolol hydrochloride. J. Drug Delivery Sci. Technol. 2021;63:102398.
Patil JS, Biradar VB, Biradar PR, Shiralashett SS, Marapur SC, Gurav PB: Design and Evaluation of Gastro retentive Drug Delivery System of Anti Ulcer Drug. J. Food. Pharm. Sci. 2015;2:1-5.
Park H, Jin Seo H, Hong S-hyeon, Ha E-S, Lee S, Kim J-S, et al. Characterization and therapeutic efficacy evaluation of Glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: Influence of molar ratio and preparation methods. Int. J. Pharm. 2020;581:119232.
Published
Abstract Display: 551 
PDF Downloads: 544 
